In recent years, clinical models have identified key signaling molecules involved in migraine, including calcitonin gene-related peptide (CGRP), pituitary adenylate cyclase-activating peptide 38 (PACAP-38), and nitric oxide, whose exposure significantly increases the risk of migraine attacks. Here, ADCYAP1 is linked to migraine disorder.